Central Trust Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
14,434
+2,862
+25% +$220K 0.02% 340
2025
Q4
$918K Buy
11,572
+905
+8% +$71.3K 0.02% 350
2025
Q3
$804K Sell
10,667
-1,873
-15% -$128K 0.02% 364
2025
Q2
$865K Buy
12,540
+1
+0% +$66 0.02% 343
2025
Q1
$850K Sell
12,539
-984
-7% -$58.9K 0.02% 338
2024
Q4
$607K Sell
13,523
-5,449
-29% -$306K 0.01% 384
2024
Q3
$1.19M Sell
18,972
-10,283
-35% -$600K 0.03% 298
2024
Q2
$1.73M Sell
29,255
-4,232
-13% -$265K 0.04% 250
2024
Q1
$2.67M Sell
33,487
-1,646
-5% -$126K 0.07% 203
2023
Q4
$2.77M Sell
35,133
-3,379
-9% -$240K 0.07% 192
2023
Q3
$2.69M Sell
38,512
-7,672
-17% -$544K 0.08% 188
2023
Q2
$3.19M Sell
46,184
-8,876
-16% -$632K 0.09% 178
2023
Q1
$4.09M Sell
55,060
-12,697
-19% -$1.06M 0.12% 143
2022
Q4
$6.31M Buy
67,757
+6,943
+11% +$670K 0.19% 99
2022
Q3
$5.8M Sell
60,814
-2,162
-3% -$214K 0.2% 93
2022
Q2
$5.83M Sell
62,976
-1,535
-2% -$150K 0.19% 99
2022
Q1
$6.53M Sell
64,511
-2,186
-3% -$230K 0.19% 102
2021
Q4
$6.88M Sell
66,697
-2,179
-3% -$201K 0.19% 100
2021
Q3
$5.84M Sell
68,876
-8,722
-11% -$731K 0.21% 102
2021
Q2
$6.47M Sell
77,598
-3,324
-4% -$272K 0.23% 93
2021
Q1
$6.09M Sell
80,922
-17,860
-18% -$1.3M 0.24% 93
2020
Q4
$6.75M Buy
98,782
+650
+0.7% +$42.3K 0.28% 84
2020
Q3
$5.73M Sell
98,132
-1,838
-2% -$114K 0.26% 86
2020
Q2
$6.5M Buy
99,970
+8,937
+10% +$563K 0.33% 71
2020
Q1
$5.4M Buy
91,033
+10,284
+13% +$687K 0.33% 75
2019
Q4
$6M Buy
80,749
+1,260
+2% +$88.5K 0.31% 75
2019
Q3
$5.01M Buy
79,489
+6,604
+9% +$391K 0.28% 89
2019
Q2
$4.23M Sell
72,885
-1,593
-2% -$85.8K 0.24% 103
2019
Q1
$4.02M Buy
74,478
+22,077
+42% +$1.36M 0.24% 99
2018
Q4
$3.43M Buy
52,401
+16,514
+46% +$1.23M 0.23% 100
2018
Q3
$2.83M Sell
35,887
-80
-0.2% -$5.72K 0.16% 132
2018
Q2
$2.31M Buy
35,967
+365
+1% +$24.1K 0.15% 146
2018
Q1
$2.21M Sell
35,602
-482
-1% -$34.6K 0.14% 150
2017
Q4
$2.62M Sell
36,084
-8,160
-18% -$593K 0.16% 128
2017
Q3
$3.6M Sell
44,244
-504
-1% -$39.9K 0.23% 102
2017
Q2
$3.6M Buy
44,748
+6,783
+18% +$536K 0.24% 107
2017
Q1
$2.98M Sell
37,965
-12,242
-24% -$977K 0.2% 118
2016
Q4
$3.96M Sell
50,207
-28,782
-36% -$2.33M 0.27% 98
2016
Q3
$7.03M Buy
78,989
+7,406
+10% +$699K 0.51% 50
2016
Q2
$6.85M Buy
71,583
+2,024
+3% +$202K 0.51% 50
2016
Q1
$7.21M Buy
69,559
+2,497
+4% +$243K 0.57% 45
2015
Q4
$6.56M Buy
67,062
+2,287
+4% +$224K 0.54% 49
2015
Q3
$6.25M Buy
64,775
+2,651
+4% +$279K 0.54% 48
2015
Q2
$6.51M Buy
62,124
+6,300
+11% +$644K 0.51% 50
2015
Q1
$5.76M Buy
55,824
+5,234
+10% +$530K 0.46% 56
2014
Q4
$4.87M Sell
50,590
-422
-0.8% -$37.2K 0.4% 62
2014
Q3
$4.06M Sell
51,012
-8
-0% -$631 0.32% 78
2014
Q2
$3.85M Buy
51,020
+2,219
+5% +$168K 0.3% 88
2014
Q1
$3.65M Buy
48,801
+1,708
+4% +$121K 0.3% 85
2013
Q4
$3.37M Buy
47,093
+10,516
+29% +$676K 0.28% 88
2013
Q3
$2.08M Buy
36,577
+1,131
+3% +$67.4K 0.19% 122
2013
Q2
$2.03M Buy
+35,446
New +$2.05M 0.19% 115

Other funds holding CVS

Central Trust Company's CVS Position: Q1 2026 in Review

Central Trust Company increased its CVS Health (CVS) stake by 25% in Q1 2026, buying an estimated $220K and bringing the position to 14,434 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #340.

Central Trust Company first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.21M in Q1 2016. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Central Trust Company held 14,434 shares of CVS Health worth $1.04M as of Q1 2026.
  • Central Trust Company bought 2,862 CVS Health shares in Q1 2026, an estimated $220K.
  • CVS Health made up 0.02% of Central Trust Company's portfolio in Q1 2026, its #340 holding.
  • Central Trust Company first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's CVS Health position peaked at $7.21M in Q1 2016.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.